<DOC>
	<DOCNO>NCT01799837</DOCNO>
	<brief_summary>The objective proposal collect pilot data characterize bind [ 11C ] MENET combat-exposed war veteran posttraumatic stress disorder ( PTSD ) . Approximately two hundred thousand veteran return stateside upon end combat operation Iraq , 13 % return veteran PTSD . 15 % war veteran develop chronic PTSD symptom require lifetime mental health care . Little known dysregulation PTSD veteran 's neurochemical state include noradrenergic system play primary role memory stress response . This include heighten anxiety , fear hyperarousal symptom characteristic PTSD . The noradrenergic system concentration neuron brainstem nucleus , locus coerulues , projection amygdale prefrontal cortex . The norepinephrine transporter ( NET ) responsible regulate terminate noradrenergic transmission , specific marker neuronal integrity . Hyperactivity noradrenergic system up-regulates NET protein . An unresolved problem study noradrenergic system identification suitable radiopharmaceutical non-invasively measure alteration density NET . The investigator propose address challenge use positron emission tomography ( PET ) measure stress-induced change NET expression combat-exposed war veteran PTSD . The central hypothesis proposal war veteran PTSD up-regulation NET locus coerulues result hyperactivity noradrenergic system compare healthy control . Through series experiment , investigator determine vivo bind characteristic [ 11C ] MENET . The investigator use information optimally design experimental protocol measure availability NET pilot group combat-exposed war veteran PTSD . The aims proposal : 1 ) Measure uptake kinetics whole brain distribution [ 11C ] MENET combat-exposed veteran PTSD healthy control , 2 ) Develop quantitative kinetic model [ 11C ] MENET uptake calculate NET availability brain . The subject undergo image work recruit Dr. J. Douglas Bremner ( Co-Investigator ) Emory University Atlanta Veteran Affairs Hospital . Our long-term goal develop longitudinal study framework assess NETs dysregulation onset PTSD well transition chronic lifetime PTSD .</brief_summary>
	<brief_title>Norepinephrine Transporter Availability PTSD</brief_title>
	<detailed_description />
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<criteria>PTSD determine Structural Clinical Interview DSMIV ( SCID ) interview PTSD Clinical Administered PTSD Scale ( CAPS ) . Veteran history active duty service currently discharge active duty service Free psychotropic medication four week study History shrapnel foreign body would preclude MRI scan Meningitis Traumatic brain injury Neurological disorder organic mental disorder History loss consciousness Current lifetime history alcohol abuse substance abuse dependence base SCID Current lifetime history schizophrenia , schizoaffective disorder , bulimia base SCID History serious medical neurological illness , cardiovascular , gastrointestinal , hepatic , renal , neurologic systemic illness Evidence major neurological illness physical examination result laboratory study positive urine toxicology screen Current steroid use</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>PTSD</keyword>
</DOC>